We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-1.94%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$107B
AUM Growth
-$13.8B
Cap. Flow
-$14.2B
Cap. Flow %
-13.33%
Top 10 Hldgs %
9.28%
Holding
6,280
New
934
Increased
1,773
Reduced
2,078
Closed
805

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$384M
2
AAPL icon
Apple
AAPL
+$377M
3
PYPL icon
PayPal
PYPL
+$368M
4
PFE icon
Pfizer
PFE
+$339M
5
SCHW
Charles Schwab
SCHW
+$319M

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.02B
2
XLNX
Xilinx Inc
XLNX
+$732M
3
NFLX icon
Netflix
NFLX
+$461M
4
C icon
Citigroup
C
+$361M
5
BKNG icon
Booking.com
BKNG
+$288M

Sector Composition

Rank Sector Weight
1 Technology 13.54%
2 Consumer Discretionary 9.06%
3 Financials 8.31%
4 Healthcare 8.05%
5 Communication Services 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTOCW
4926
DELISTED
Pine Technology Acquisition Corp. Warrant
PTOCW
$64K ﹤0.01%
284,945
BRD.WS
4927
DELISTED
Beard Energy Transition Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
BRD.WS
$64K ﹤0.01%
+199,999
New +$75K
CRMD icon
4928
CorMedix
CRMD
$667M
$63K ﹤0.01%
+11,495
New +$52.6K
DRIO icon
4929
DarioHealth
DRIO
$72.4M
$63K ﹤0.01%
+543
New +$89.8K
NGD
4930
DELISTED
New Gold Inc
NGD
$63K ﹤0.01%
35,086
+19,531
+126% +$33.6K
DNA.WS
4931
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$63K ﹤0.01%
71,236
LOCL.WS
4932
DELISTED
Local Bounti Corporation Every 13 warrants will be exercisable for one share of common stock at an exercise price of $149.50 per share of common stock
LOCL.WS
$63K ﹤0.01%
33,320
NOVN
4933
DELISTED
Novan, Inc. Common Stock
NOVN
$63K ﹤0.01%
16,083
-26,970
-63% -$99.2K
AGGRW
4934
DELISTED
Agile Growth Corp Warrant
AGGRW
$63K ﹤0.01%
218,353
MLAIW
4935
DELISTED
McLaren Technology Acquisition Corp. Warrant
MLAIW
$63K ﹤0.01%
+300,000
New +$92.1K
GTYH
4936
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
$63K ﹤0.01%
19,363
+3,661
+23% +$17K
AYTU icon
4937
AYTU BioPharma
AYTU
$25.2M
$61K ﹤0.01%
2,816
-2,666
-49% -$66.3K
SGTX
4938
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$61K ﹤0.01%
3,189
-368
-10% -$8.2K
NGC.WS
4939
DELISTED
Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share
NGC.WS
$61K ﹤0.01%
126,627
-11,837
-9% -$7.78K
EAR
4940
DELISTED
Eargo, Inc. Common Stock
EAR
$61K ﹤0.01%
581
-13,999
-96% -$1.38M
VSEEW
4941
DELISTED
VSEE HEALTH INC WTS 29
VSEEW
$60K ﹤0.01%
+365,000
New +$85.4K
SFE
4942
DELISTED
Safeguard Scientifics, Inc.
SFE
$60K ﹤0.01%
11,486
-27,615
-71% -$167K
BIOSW
4943
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
$60K ﹤0.01%
+272,750
New +$70.8K
RJAC.WS
4944
DELISTED
Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
RJAC.WS
$60K ﹤0.01%
+300,000
New +$107K
ACDI.WS
4945
DELISTED
Ascendant Digital Acquisition Corp. III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11. 50 per share
ACDI.WS
$60K ﹤0.01%
+150,000
New +$71.4K
TMAC.WS
4946
DELISTED
The Music Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TMAC.WS
$60K ﹤0.01%
269,562
ABUS icon
4947
Arbutus Biopharma
ABUS
$1.03B
$59K ﹤0.01%
19,698
-3,202
-14% -$9.8K
RDZNW icon
4948
Roadzen Inc Warrants
RDZNW
$59K ﹤0.01%
+175,000
New +$59.7K
ENCPW
4949
DELISTED
Energem Corp Warrant
ENCPW
$59K ﹤0.01%
+300,000
New +$63K
GDNRW
4950
DELISTED
Gardiner Healthcare Acquisitions Corp. Warrant
GDNRW
$59K ﹤0.01%
+300,000
New +$74.3K

Similar funds

David Shaw's Q1 2022 Portfolio in Review

As of Q1 2022, David Shaw held 6,280 positions worth $107B, down 11% from $121B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

David Shaw withdrew a net $14.2B in Q1 2022, closing 805 positions and reducing 2,078 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.02B position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, David Shaw opened a new position in Cenovus Energy worth $141M.

  • David Shaw's largest Q1 2022 buy was Cenovus Energy: 8,428,527 shares worth $141M.
  • David Shaw added most to Starbucks in Q1 2022, an estimated $384M increase.
  • David Shaw's biggest Q1 2022 reduction was Netflix, cutting an estimated $461M.
  • David Shaw fully exited iShares Core S&P 500 ETF in Q1 2022, selling an estimated $1.02B.
  • David Shaw's ten largest holdings make up 9.3% of its $107B portfolio in Q1 2022.
  • David Shaw opened 934 new positions and closed 805 in Q1 2022.
  • David Shaw's portfolio value fell 11% quarter-over-quarter to $107B.

Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.